Both USPs are associated with poor prognosis of cancer patients, and they are also involved in the regulation of several overlapping targets and signaling pathways such as p53/Foxp3/PD-L1/HIF1A and H2Bub1 which are critical to cancer development and therapy response. Here, FOXP3 is linked to cancer.